Search fresh public links, source activity, and ready-to-use post angles for Buy-And-Bill.
Fresh curated links around Buy-and-Bill are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
By Tyler Novotny and Bryce Platt PBM-affiliated private label biosimilars would seem to have a built-in formulary advantage. But for ustekinumab, that advantage has not carrie...
On October 12, 2026, Drug Channels Institute will release our 2026-27 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors. The U.S. prescription drug marke...
This week, we're rerunning some popular posts while we put the finishing touches on DCI’s 2026-27 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors. Clic...
Amazon and GoodRx are selling cash-pay prescription plans to insured workers. Those purchases usually sit outside the group plan, which matters for deductibles, claims data and 202...
Three federal pricing changes are about to land on a single outpatient claim. The largest infusion and oncology programs will feel them first, and hardest. Most of the 340B debate...
The model offers members potential savings of up to $150,000, executives say.
By JOHN SAMARAS A US retail pharmacy pays $1,302 to acquire one month of branded Wegovy. That figure comes from the Centers for Medicare and Medicaid Services National Average Drug...
An analysis of commercial claims for 106 physician-administered outpatient drugs suggests $101 of additional plan spending per member per year stemming from site-of-treatment pay d...
Epic is bringing pharmacy price shopping directly into the doctor's office and the prescribing workflow.
The true cost of “vertical integration”: patients directed to a higher-priced location for procedures. Or forced to buy from their insurer’s wholly owned pharmacy, which may not st...
BD plans to increase U.S. production of essential medical consumables in exchange for relief from future tariffs on its products.
Drug Channels Institute is pleased to announce the availability of our 2026-27 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors. The U.S. prescription d...
Digital health company Waltz Health is teaming up with drugmaker Fresenius Kabi to support direct-to-employer efforts for key biosimilar medications.
The IRA Fixed One Medicare Part D Distortion—But Patients Now Face New Tradeoffs (rerun) Anonymous (not verified) Thu, 10/08/2026 - 07:08 pharmagather item url...
On Oct. 2, 2026, the Centers for Medicare & Medicaid Services (CMS) published the final rule for the Global Benchmark for Efficient Drug Pricing (GLOBE) Model. GLOBE is a manda...
The Trump administration has finalized a new model that aims to bring its most-favored nation pricing approach to Medicare Part B.
The Bridge program, which began July 1, makes some Medicare beneficiaries eligible for obesity drugs for $50 a month. CVS and Walgreens say they've each already filled 100,000 such...
By Bryce Platt, PharmD For more than a decade, the answer to “Where do drug wholesalers make their money?” has been generic drugs. Although wholesaler revenues are linked mo...
Option Care Health, the country's largest independent provider of at-home and alternate site infusion services, would go private in the deal, which is expected to close in the firs...
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.